- According to estimates from 28 analysts, Biogen Inc. stock's average price target has risen from $230.32 to $231.82, with forecasts ranging from $157 to $300 per share
- Based on the Jul. 28 closing price, the updated target implies approximately 13% potential upside
- Consensus rating remains at “Buy” across 36 covering analysts, with 22 Buys, 12 Holds and 2 Sells
Explore more price target data and ratings for Biogen Inc. on the , and track all previous and future analyst recommendations for Biogen Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.